Alembic Pharma gets USFDA nod for neuropathic pain management drug

The approval from the United States Food and Drug Administration (USFDA) is for the company#39;s abbreviated new drug application (ANDA) for Pregabalin Capsules in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg, Alembic Pharmaceuticals said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2JKrs31